Trial Profile
Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine in HIV-infected Adults: A Randomized Control Trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Rilpivirine (Primary) ; Efavirenz
- Indications HIV-1 infections
- Focus Adverse reactions
- 29 Jun 2018 New trial record